Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups

Omran Saifi, Chelsea C. Pinnix, Chris R. Kelsey, Leslie K. Ballas, Sarah A. Milgrom, Ranjana Advani, Margaret T. Kasner, Stella Flampouri, Stephanie A. Terezakis, Mark Sellmyer, John P. Plastaras, Bradford S. Hoppe

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

There has been a notable decrease in the use of radiation in lymphoma clinical practice and research in recent years. The NRG Hematologic Malignancies Working Group aimed to assess the inclusion of radiation oncology alongside haematology and oncology, pathology and molecular biology, and diagnostic radiology and nuclear medicine in lymphoma academic leadership positions. The haematology and oncology specialty had the highest representation among National Comprehensive Cancer Network lymphoma guideline committees, lymphoma research cooperative groups, lymphoma research foundations, and the editorial boards of seven high-impact haematology journals, with under-representation of radiation oncology and other specialties, such as diagnostic radiology and nuclear medicine. The NRG Hematologic Malignancies Working Group advocates for increased multidisciplinary representation and collaboration to enhance the quality of care and improve outcomes for patients with lymphoma.

Original languageEnglish (US)
Pages (from-to)e555-e559
JournalThe Lancet Haematology
Volume12
Issue number7
DOIs
StatePublished - Jul 2025

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Ltd

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups'. Together they form a unique fingerprint.

Cite this